American Shared Hospital Services (NYSEAMERICAN:AMS) Stock Passes Above 200-Day Moving Average – What’s Next?

American Shared Hospital Services (NYSEAMERICAN:AMS) passed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $0.00 and traded as high as $2.51. American Shared Hospital Services shares last traded at $2.41, with a volume of 18,162 shares.

Analyst Ratings Changes

Separately, Wall Street Zen assumed coverage on American Shared Hospital Services in a report on Friday, May 16th. They issued a “hold” rating for the company.

American Shared Hospital Services Price Performance

The company’s fifty day moving average is $2.63. The stock has a market capitalization of $15.47 million, a price-to-earnings ratio of 4.02 and a beta of 0.66. The company has a current ratio of 1.46, a quick ratio of 1.46 and a debt-to-equity ratio of 0.34.

Hedge Funds Weigh In On American Shared Hospital Services

An institutional investor recently raised its position in American Shared Hospital Services stock. Renaissance Technologies LLC raised its position in shares of American Shared Hospital Services (NYSEAMERICAN:AMS) by 5.6% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 71,225 shares of the company’s stock after acquiring an additional 3,776 shares during the quarter. Renaissance Technologies LLC owned approximately 1.11% of American Shared Hospital Services worth $227,000 as of its most recent SEC filing. 23.16% of the stock is currently owned by institutional investors and hedge funds.

American Shared Hospital Services Company Profile

American Shared Hospital Services provides stereotactic radiosurgery and advanced radiation therapy equipment. It operates in two segments, Medical Equipment Leasing, and Retail. The company offers radiosurgery equipment for the Gamma Knife stereotactic radiosurgery, a non-invasive procedure to treat malignant and benign brain tumors, and arteriovenous malformations, as well as for trigeminal neuralgia.